drugset / Trial / NCT04090684
Ciprofloxacin/Celecoxib Combination in Patients With ALS
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, off label study, to provide interested ALS patients with Ciprofloxacin/Celecoxib fixed dose combination, while assessing safety and tolerability, routine disease progression measures (ALSFRS-R and Vital Capacity).
Timeline
- Start
- 2019-12-09
- Primary completion
- 2021-09-27
- Completion
- 2022-01-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | — | — |
| Subject | Ciprofloxacin | Small molecule | — | — |